Stay updated on Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Sign up to get notified when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    UI and metadata updates include a glossary toggle, a new label 'Last Update Submitted that Met QC Criteria' for QC status, capitalization changes for 'No FEAR Act Data', and a new page revision indicator 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-27T20:01:57.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-20T14:38:43.000Z thumbnail image
  3. Check
    37 days ago
    Change Detected
    Summary
    Added new study locations: Fujian, Gansu, Heilongjiang, Henan, Shandong, Sichuan, Tianjin Municipality, Zhejiang (China) and Gyeonggi-do, Seoul Teugbyeolsi (South Korea). Updated revision tag from v3.3.2 to v3.3.3.
    Difference
    1%
    Check dated 2025-12-22T21:56:34.000Z thumbnail image
  4. Check
    58 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.1 to v3.3.2 on the page, with no changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T11:43:23.000Z thumbnail image
  5. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.3.1 updated from v3.2.0.
    Difference
    0.0%
    Check dated 2025-11-24T12:37:40.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Removed the government funding status notice warning of possible delays and limited inquiries. The notice related to site operations and not to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:22:24.000Z thumbnail image

Stay in the know with updates to Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efficacy Safety Tislelizumab Fruquintinib Combo Clinical Trial page.